IN8bio, Inc. (INAB)
NASDAQ: INAB · Real-Time Price · USD
1.630
-0.050 (-2.98%)
Dec 15, 2025, 11:57 AM EST - Market open
IN8bio Market Cap
IN8bio has a market cap or net worth of $7.55 million as of December 15, 2025. Its market cap has decreased by -66.38% in one year.
Market Cap
7.55M
Enterprise Value
53.79K
1-Year Change
-66.38%
Ranking
Category
Stock Price
$1.63
Market Cap Chart
Since the IPO on July 30, 2021, IN8bio's market cap has decreased from $187.55M to $7.55M, a decrease of -95.97%. That is a compound annual growth rate of -52.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 12, 2025 | 7.79M | -58.24% |
| Dec 31, 2024 | 18.64M | -68.76% |
| Dec 29, 2023 | 59.67M | 5.43% |
| Dec 30, 2022 | 56.60M | -31.25% |
| Dec 31, 2021 | 82.33M | -56.10% |
| Jul 30, 2021 | 187.55M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 920.02B |
| Johnson & Johnson | 509.76B |
| AbbVie | 394.69B |
| UnitedHealth Group | 309.65B |
| AstraZeneca | 278.45B |
| Novartis AG | 254.39B |
| Merck & Co. | 248.95B |
| Novo Nordisk | 224.22B |